Abstract |
Scutellaria baicalensis (S.B.) is a widely used Chinese herbal medicine. We initially investigated its in vitro anti- tumor activities. S.B inhibited the growth of ALL, lymphoma and myeloma cell lines by inducing apoptosis and cell cycle arrest at clinically achievable concentrations. The anti-proliferative effect was associated with mitochondrial damage, modulation of the Bcl family of genes, increased level of the CDK inhibitor p27(KIP1) and decreased level of c-myc oncogene. HPLC analysis of S.B. showed it contains 21% baicalin and further studies confirmed it was the major anti- cancer component of S.B. Thus, Scutellaria baicalensis should be tested in clinical trials for these hematopoietic malignancies.
|
Authors | Takashi Kumagai, Claudia I Müller, Julian C Desmond, Yasufumi Imai, David Heber, H Phillip Koeffler |
Journal | Leukemia research
(Leuk Res)
Vol. 31
Issue 4
Pg. 523-30
(Apr 2007)
ISSN: 0145-2126 [Print] England |
PMID | 17007926
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Drugs, Chinese Herbal
- Flavonoids
- Cyclin-Dependent Kinase Inhibitor p27
- baicalin
|
Topics |
- Antineoplastic Agents, Phytogenic
(therapeutic use)
- Apoptosis
(drug effects)
- Blotting, Western
- Cell Cycle
(drug effects)
- Cell Proliferation
(drug effects)
- Colony-Forming Units Assay
- Cyclin-Dependent Kinase Inhibitor p27
(metabolism)
- Drug Screening Assays, Antitumor
- Drugs, Chinese Herbal
(therapeutic use)
- Flavonoids
(therapeutic use)
- Flow Cytometry
- Humans
- Membrane Potential, Mitochondrial
(drug effects)
- Multiple Myeloma
(drug therapy, metabolism, pathology)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, metabolism, pathology)
- Scutellaria baicalensis
(chemistry)
- Tumor Cells, Cultured
(drug effects)
|